Susan Morgello1,2, Gary Gensler3, Seth Sherman3, Ronald J Ellis4, Benjamin B Gelman5, Dennis L Kolson6, Scott L Letendre7, Jessica Robinson-Papp1, Leah H Rubin8, Elyse Singer9, Miguel Valdes-Sueiras9. 1. Department of Neurology, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York. 2. Departments of Neuroscience and Pathology, ISMMS, New York, New York. 3. The Emmes Company, Rockville, Maryland. 4. Departments of Neurosciences and Psychiatry, University of California, San Diego, California. 5. Department of Pathology, University of Texas Medical Branch, Galveston, Texas. 6. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 7. Departments of Psychiatry and Medicine, University of California, San Diego, California. 8. Departments of Neurology and Epidemiology, Johns Hopkins Schools of Medicine and Public Health, Baltimore, Maryland. 9. Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Abstract
OBJECTIVES: Multimorbidity and frailty are consequences of aging with HIV, yet not everyone with medical disease is frail. Our objective was to identify factors associated with frailty in a multimorbid HIV-infected cohort. DESIGN: Analysis of a prospective, observational, longitudinal cohort. METHODS: Three hundred and thirty-two participants in the medically advanced National NeuroAIDS Tissue Consortium (NNTC) study were categorized as frail, prefrail, or robust with the Fried Frailty Index. A series of logistic regression analyses (first univariate, then multivariable) were conducted to determine whether medical comorbidities, immunologic and virologic parameters, and/or neuropsychiatric variables predicted increased odds of frailty. RESULTS: The mean number of medical comorbidities per participant was 2.7, mean CD4 T-cell count was 530 cells/μl, and 77% had undetectable HIV RNA in blood. Twenty-two percent were frail, 55% prefrail, and 23% robust. Significant predictors of frailty in multivariable analysis were cognitive diagnosis rendered by Frascati criteria, depressive symptoms, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and sex. Men were less likely to be frail than women. Higher odds of frailty were seen with: symptomatic, but not asymptomatic, cognitive impairment (compared with cognitive normals); more depressive symptoms; diabetes mellitus; and COPD. CONCLUSION: Neuropsychiatric illness increased odds of being frail on a predominantly physical/motoric measure, but only when symptomatic. Lack of association with asymptomatic impairment may reflect the importance of functional limitation to frailty, or possibly a unique resilience phenotype. Understanding why sex and symptomatic neuropsychiatric illness are associated with frailty will be important in managing HIV-associated morbidity in aging populations.
OBJECTIVES: Multimorbidity and frailty are consequences of aging with HIV, yet not everyone with medical disease is frail. Our objective was to identify factors associated with frailty in a multimorbid HIV-infected cohort. DESIGN: Analysis of a prospective, observational, longitudinal cohort. METHODS: Three hundred and thirty-two participants in the medically advanced National NeuroAIDS Tissue Consortium (NNTC) study were categorized as frail, prefrail, or robust with the Fried Frailty Index. A series of logistic regression analyses (first univariate, then multivariable) were conducted to determine whether medical comorbidities, immunologic and virologic parameters, and/or neuropsychiatric variables predicted increased odds of frailty. RESULTS: The mean number of medical comorbidities per participant was 2.7, mean CD4 T-cell count was 530 cells/μl, and 77% had undetectable HIV RNA in blood. Twenty-two percent were frail, 55% prefrail, and 23% robust. Significant predictors of frailty in multivariable analysis were cognitive diagnosis rendered by Frascati criteria, depressive symptoms, diabetes mellitus, chronic obstructive pulmonary disease (COPD), and sex. Men were less likely to be frail than women. Higher odds of frailty were seen with: symptomatic, but not asymptomatic, cognitive impairment (compared with cognitive normals); more depressive symptoms; diabetes mellitus; and COPD. CONCLUSION:Neuropsychiatric illness increased odds of being frail on a predominantly physical/motoric measure, but only when symptomatic. Lack of association with asymptomatic impairment may reflect the importance of functional limitation to frailty, or possibly a unique resilience phenotype. Understanding why sex and symptomatic neuropsychiatric illness are associated with frailty will be important in managing HIV-associated morbidity in aging populations.
Authors: Robert H Paul; Kyu S Cho; Patrick Luckett; Jeremy F Strain; Andrew C Belden; Jacob D Bolzenius; Jaimie Navid; Paola M Garcia-Egan; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Abel Obosi; Julie A Mannarino; Beau M Ances Journal: J Acquir Immune Defic Syndr Date: 2020-08-01 Impact factor: 3.731
Authors: Robert H Paul; Cecilia M Shikuma; Nguyen Van Vinh Chau; Lishomwa C Ndhlovu; Nguyen Tat Thanh; Andrew C Belden; Dominic C Chow; Glen M Chew; Thomas A Premeaux; Vo Trieu Ly; Joseph A D McBride; Jacob D Bolzenius; Thuy Le Journal: Front Neurol Date: 2021-03-12 Impact factor: 4.003
Authors: Alyssa Vecchio; Gertrude Nakigozi; Noeline Nakasujja; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Kevin Robertson; Maria J Wawer; Ned Sacktor; Leah H Rubin; Deanna Saylor Journal: J Neurovirol Date: 2021-03-31 Impact factor: 2.643
Authors: David R Lorenz; Shibani S Mukerji; Vikas Misra; Hajime Uno; Benjamin B Gelman; David J Moore; Elyse J Singer; Susan Morgello; Dana Gabuzda Journal: AIDS Date: 2021-12-01 Impact factor: 4.177